---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-311319"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T16:56:18.816753+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Nuvation Bio terminates collaboration agreement with SPARCBIO LLC effective Jan 2022

## Summary
- On Oct 22, 2021, Nuvation notified SPARCBIO LLC of termination effective Jan 21, 2022 without penalty.
- The collaboration agreement was originally dated Jan 21, 2019 among Nuvation, RePharmation, and SPARCBIO LLC.
- Company stated it no longer requires the services under the collaboration agreement.
- No additional costs, penalties, or new agreements were disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-21-311319
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312521311319/0001193125-21-311319-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312521311319/d162622d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-311319
- JSON: https://secwatch.observer/filing/0001193125-21-311319.json
- Plain text: https://secwatch.observer/filing/0001193125-21-311319.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.